Statin use and delayed onset of Huntington’s disease. Schultz JL, Nopoulos PC, Killoran A, Kamholz JA. Mov Disord 2019; 34:281-285. Abstract BACKGROUND: There is evidence to suggest that 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors (statins) may be beneficial in Huntington’s disease (HD). OBJECTIVE: This study aimed to determine if statin use was associated with delayed motor diagnosis in participants with premotor HD. METHODS: Among premotor […] via Do statins delay motor progression of Huntington’s disease? — Neurochecklists Blog from The Neurology Lounge https://ift.tt/2NOGVl9